𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular characterization of galactosemia (Type 1)mutations in Japanese

✍ Scribed by Jiro Ashino; Yoshiyuki Okano; Itsuzin Suyama; Takeshi Yamazaki; Makoto Yoshino; Jun-Ichi Furuyama; Hsien-Chin Lin; Juergen K. V. Reichardt; Gen Isshiki


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
631 KB
Volume
6
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Cummunicated by Sauio L. C. Woo

We characterized two novel mutations of the galactose-1-phosphate uridyltransferase (GALT) gene in two Japanese patients with GALT deficiency and identified N 3 14D and R333W mutations, previously found in Caucasians. One novel missense mutation was an G-to-A transition in exon 8, resulting in the substitution of arginine by histidine at the codon 23 1 (R23 1H). GALT activity of the R23 1H mutant construct was reduced to 15% of normal controls in a COS cell expression system. The other was a splicing mutation, an A-to-G transition at the 38th nucleotide in exon 3 (318A+G), resulting in a 38-bp deletion in the GALT cDNA by activating a cryptic splice acceptor site. In seven Japanese families (14 alleles for classic form and one allele for Duarte variant) with GALT deficiency, the R231H and 318A-G mutations were found only on both alleles of the proband. T h e N314D and R333W mutations were found on one allele each. The Q l 8 8 R was prevalent in the United States but not in Japanese patients. The N314D mutation was associated with the Duarte variant in Japanese persons, as well as in the United States. We speculate that classic galactosemia mutations appear to differ between Japanese and Caucasian patients. Our limited data set on galactosemia mutations in Japanese suggests that the N 3 14D GALT mutation encoding the Duarte variant arose before Asian and Caucasian people diverged and that classic galactosemia mutations arose and/or accumulated after the divergence of Asian and Caucasian populations.


πŸ“œ SIMILAR VOLUMES


Structural and molecular biology of type
✍ Thomas J. McCorvie; David J. Timson πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 431 KB

## Abstract Type I galactosemia results from reduced galactose 1‐phosphate uridylyltransferase (GALT) activity. Signs of disease include damage to the eyes, brain, liver, and ovaries. However, the exact nature and severity of the pathology depends on the mutation(s) in the patient's genes and his/h

Molecular analysis of neurofibromatosis
✍ Xu Weiming; Qi Yu; Liu Lizhi; Margaret Ponder; Margaret Wallace; Xu Gangfeng; Br πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 377 KB

## Communicated by Robert Williamson We have examined a panel of 115 unrelated N F l individuals for mutation in the 3' region of the N F l gene, using Southern blotting and polymerase chain reaction amplification of exons followed by singlestrand conformation polymorphism (SSCP) analysis. We foun

The structural and molecular biology of
✍ Thomas J. McCorvie; David J. Timson πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 276 KB

Reduced galactose 1-phosphate uridylyltransferase (GALT) activity is associated with the genetic disease type I galactosemia. This results in an increase in the cellular concentration of galactose 1-phosphate. The accumulation of this toxic metabolite, combined with aberrant glycoprotein and glycoli

Characterization of six mutations in exo
✍ Upadhyaya, Meena; Osborn, Mike; Maynard, Julie; Harper, Peter πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 326 KB πŸ‘ 1 views

Neurofibromatosis type 1 ("1) is one of the most common inherited disorders, with an incidence of 1 in 3,000. We screened a total of 320 unrelated NF1 patients for mutations in exon 37 of the NF1 gene. Six independent mutations were identified, of which three are novel, and these include a recurrent